Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Feb;89(2):356–364. doi: 10.1172/JCI115593

Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia.

S Karpatkin 1, M Nardi 1
PMCID: PMC442860  PMID: 1737832

Abstract

Autoimmune antiidiotype-like antibody (Ab2) directed against anti-HIV-1gp120 (Ab1) was found in high titer in the sera of 10 consecutive homosexual and 11 narcotic addict HIV-1-related immunologic thrombocytopenia (HIV-1-ITP) patients, was barely detectable in 10 nonthrombocytopenic HIV-1 sero-positive individuals, and was not detectable in 5 normal subjects by use of a solid-phase RIA. Reactivity of autologous Ab2 for Ab1 was 4-120-fold greater than Ab2 for homologous Ab1. Affinity-purified Ab2 did not block the binding of affinity-purified Ab1 to its HIV-1gp120 epitopes on immunoblot, indicating the absence of "internal image" antiidiotype. Both Ab1 and Ab2 are precipitable from sera with polyethylene glycol (PEG) and present in a macromolecular complex that is excluded by gel filtration on G200 and contains IgG, IgM, C3, and the anti-F(ab')2 antiidiotype-like complex. PEG-precipitable complexes bind to platelets in a saturation-dependent manner. Neither affinity-purified Ab1 nor Ab2 binds to platelets. However, the combination of Ab1 and Ab2 (preincubated for 2 h at 22 degrees C) binds to platelets in a saturation-dependent manner at an optimum ratio range of 10-20:1. Ab2 reactivity correlates with serum PEG-precipitable immune complex level (r = 0.91; P less than 0.001) and with thrombocytopenia (r = 0.89; P less than 0.001). We suggest that the anti-HIV-1gp120 antiidiotype-like complex contributes to the markedly elevated platelet Ig and C3 level of HIV-1-ITP patients and propose that this may contribute to their thrombocytopenia.

Full text

PDF
356

Images in this article

362Image
on p.362
362Image
on p.362
362Image
on p.362
362Image
on p.362
362Image
on p.362
362Image
on p.362

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basch R. S., Kouri Y. H., Karpatkin S. Expression of CD4 by human megakaryocytes. Proc Natl Acad Sci U S A. 1990 Oct;87(20):8085–8089. doi: 10.1073/pnas.87.20.8085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hymes K. B., Greene J. B., Karpatkin S. The effect of azidothymidine on HIV-related thrombocytopenia. N Engl J Med. 1988 Feb 25;318(8):516–517. doi: 10.1056/NEJM198802253180812. [DOI] [PubMed] [Google Scholar]
  3. Karpatkin S., Nardi M. A. Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia. J Lab Clin Med. 1988 Apr;111(4):441–448. [PubMed] [Google Scholar]
  4. Karpatkin S., Nardi M., Lennette E. T., Byrne B., Poiesz B. Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9763–9767. doi: 10.1073/pnas.85.24.9763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lyman B., Rosenberg L., Karpatkin S. Biochemical and biophysical aspects of human platelet adhesion to collagen fibers. J Clin Invest. 1971 Sep;50(9):1854–1863. doi: 10.1172/JCI106677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Morris L., Distenfeld A., Amorosi E., Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med. 1982 Jun;96(6 Pt 1):714–717. doi: 10.7326/0003-4819-96-6-714. [DOI] [PubMed] [Google Scholar]
  7. Parbtani A., Kinlough-Rathbone R. L., Chahil A., Richardson M., Mustard J. F. Survival of rabbit platelets exposed to immune complexes. Exp Mol Pathol. 1990 Feb;52(1):109–121. doi: 10.1016/0014-4800(90)90063-j. [DOI] [PubMed] [Google Scholar]
  8. Ratnoff O. D., Menitove J. E., Aster R. H., Lederman M. M. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII). N Engl J Med. 1983 Feb 24;308(8):439–442. doi: 10.1056/NEJM198302243080808. [DOI] [PubMed] [Google Scholar]
  9. Savona S., Nardi M. A., Lennette E. T., Karpatkin S. Thrombocytopenic purpura in narcotics addicts. Ann Intern Med. 1985 Jun;102(6):737–741. doi: 10.7326/0003-4819-102-6-737. [DOI] [PubMed] [Google Scholar]
  10. Stella C. C., Ganser A., Hoelzer D. Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest. 1987 Aug;80(2):286–293. doi: 10.1172/JCI113071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stricker R. B., Abrams D. I., Corash L., Shuman M. A. Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med. 1985 Nov 28;313(22):1375–1380. doi: 10.1056/NEJM198511283132202. [DOI] [PubMed] [Google Scholar]
  12. Walsh C. M., Nardi M. A., Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med. 1984 Sep 6;311(10):635–639. doi: 10.1056/NEJM198409063111004. [DOI] [PubMed] [Google Scholar]
  13. Yu J. R., Lennette E. T., Karpatkin S. Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. J Clin Invest. 1986 Jun;77(6):1756–1761. doi: 10.1172/JCI112498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. van der Lelie J., Lange J. M., Vos J. J., van Dalen C. M., Danner S. A., von dem Borne A. E. Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection. Br J Haematol. 1987 Sep;67(1):109–114. doi: 10.1111/j.1365-2141.1987.tb02304.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES